Search

Search Results
Results 1 - 10 of 73 for Refractories
  • Supplier Profile
    The NETZSCH Group is a mid-sized, family-owned German company engaging in the manufacture of machinery and instrumentation with worldwide production, sales, and service branches. The three Business...
  • Supplier Profile
    Innovnano manufactures a diverse range of high quality, ultra-fine nanostructured ceramic powders designed specifically for clients producing the next generation of advanced engineering products and...
  • Supplier Profile
    InRedox develops, designs and manufactures nanostructured materials and components based on self-organized nanoporous Anodic Aluminum Oxide (AAO) and nanotubular Anodic Titanium Oxide (ATO) –...
  • Supplier Profile
    Applied Physics Technologies, incorporated in 1995 by William Mackie and Gary Cabe, is an outgrowth of research conducted for over a decade at Linfield Research Institute on transition metal carbides,...
  • Supplier Profile
    In 1936, the Laboratory Equipment Company introduced the first rapid carbon determinator to the American iron and steel industry. Today, 75 years later, LECO is recognized globally as a leader in...
  • Supplier Profile
    Kaier Nano powders of Carbides, Nitrides, Borides & Silicon are manufactured by Plasma Arc Vapor Synthesis technology & reactor patented by the Hefei Kaier Nanotechnology Development...
  • Article - 2 Apr 2004
    Researchers from Tomsk have invented and manufactured a device to produce a choice selection of nanoparticles – all particles are equal to the required size and inexpensive. Posted March 26 2004
  • News - 8 Jan 2015
    ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi® platform, today reported that...
  • News - 28 Mar 2014
    Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that patients have been enrolled in an investigator-initiated...
  • News - 2 Jun 2015
    Dicerna Pharmaceuticals, Inc., a leader in the development of RNAi therapeutics, today presented preliminary safety and efficacy data from an ongoing Phase 1 study of DCR-MYC in patients with advanced...